Dr. Aimee Lucinda Pierce, MD

Dr. Pierce practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Pierce's NPI, 1043484801, was assigned on April 14, 2008. Dr. Pierce graduated from Columbia University College of Physicians and Surgeons in 2004. Dr. Pierce holds Oregon license MD189195.

Dr. Pierce's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Pierce's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Pierce to 1 more clinical lab, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pierce practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Pierce's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Pierce is licensed in Oregon.

CMS data shows 279 Medicare services from Dr. Pierce across 5 procedure codes in 2024, for 89 Medicare patients. Medicare paid $15,542 for them. Every service was in an office.

CMS counts 89 Medicare patients who saw Dr. Pierce in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have alzheimer's and dementia, and 51% have mood disorders. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pierce's median patient age at 76, with 53% women.

In 2024, Dr. Pierce wrote 786 Medicare Part D claims for 122 patients. 96% of them were for generic drugs. CMS names the drug for 700 of them, across 17 drugs with 11 or more claims each, at $34,867 in total drug cost. In 2023, CMS named 588 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Pierce for performance year 2024, reported through an alternative payment model (APM). Dr. Pierce accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pierce as offering telehealth.

Dmand AI links 15 papers to Dr. Pierce, published from 2016 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Alzheimer Disease, Aging and Biomedical Research. Dr. Pierce has published most often in Alzheimer Dis Assoc Disord. Dr. Pierce's most frequent co-authors are Jeffrey Alan Kaye, MD, Jeffrey M. Burns, MD and Malcolm B. Dick, PhD.

Dmand AI links Dr. Pierce to 9 clinical trials, 2 of them phase 2 studies. Conditions studied include Alzheimer Disease, Cognitive Dysfunction and Tauopathies. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Pierce that name 3 trials.

CMS Open Payments shows 21 general payments to Dr. Pierce from 3 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 49% of the total. Eisai Inc. paid the most, $1,455. It also lists 3 research payments totaling $3,555 from 2018 to 2022, naming 3 clinical trials.

Dr. Pierce graduated from Columbia University College of Physicians and Surgeons in 2004.